- Vienna '18
- Athens 2019
- ESCRS Player
- On Demand
- ESCRS iLearn
- ESCRS YO's
First Author: S.Chung SOUTH KOREA
Co Author(s): Y. Ahn
Back to previous
To evaluate the effectiveness of cyclosporine 0.05% for dry eye after cataract surgery.
The Catholic University of Korea, St. Marys Hospital, Seoul, Korea
Thirty-two newly diagnosed patients with dry eye syndrome, 1 week after cataract surgery, received a twice-daily treatment of cyclosporine 0.05% (Restasis®, Allergan, Inc., Irvine, CA, U.S.A.) for one eye and normal saline 0.9% for the other. Disease severity was measured at 2 weeks, 1 month, 2 months, and 3 months by Schirmer test I (ST-I), tear film break-up time (tBUT), corneal temperature, and a dry eye symptom questionnaire (OSDI).
Both groups increased in ST-I and tBUT over time. ST-I in the cyclosporine 0.05% group showed a significant increase at 3 months, and tBUT in the cyclosporine 0.05% group showed an increase at 2 and 3 months. The dry eye symptom score was significantly reduced in the cyclosporine 0.05% group.
Cyclosporine 0.05% can be an effective treatment for dry eye after cataract surgery.